Paul Knaapen

Showing 1-6 of 6 articles

Coronary collaterals and myocardial viability in patients with chronic total occlusions

Schumacher S, Everaars H, Stuijfzand W, Huynh J, van Diemen P, Bom M, de Winter R, van Loon R, van de Ven P, van Rossum A, Opolski M, Nap A, Knaapen P

August 7, 2020 | 10.4244/EIJ-D-19-01006

Ischaemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary intervention

Schumacher S, Kockx M, Stuijfzand W, Driessen R, van Diemen P, Bom M, Everaars H, Raijmakers P, Boellaard R, van Rossum A, Opolski M, Nap A, Knaapen P

August 7, 2020 | 10.4244/EIJ-D-19-00631

Coronary interventions

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quirós A, de Hoyos A, Broyd C, Nijjer S, van de Hoef T, Petraco R, Driessen R, Mejía-Rentería H, Kikuta Y, Pinto M, van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation

Hollander M, van Leeuwen M, van der Heijden D, Keizer V, van de Ven P, IJsselmuiden S, Van Mieghem N, Amoroso G, Ritt M, Knaapen P, van Royen N

February 20, 2017 | 10.4244/EIJ-D-16-00337

Coronary interventions

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P

August 5, 2016 | 10.4244/EIJV12I5A98

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease